Selected research
Industry Research
Percutaneous Transluminal Angioplasty Instrument Industry Research Report 2026
Market perspective
The global Percutaneous Transluminal Angioplasty Instrument market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Percutaneous Transluminal Angioplasty Instrument market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Percutaneous Transluminal Angioplasty Instrument market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Percutaneous Transluminal Angioplasty Instrument market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Percutaneous Transluminal Angioplasty Instrument include Abbott, Boston Scientific, Medtronic, Terumo Medical, Lepu Medical, MicroPort, Biosensors, B.Braun and Atrium Medical, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Percutaneous Transluminal Angioplasty Instrument market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Percutaneous Transluminal Angioplasty Instrument.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Percutaneous Transluminal Angioplasty Instrument Market by Company
Abbott
Boston Scientific
Medtronic
Terumo Medical
Lepu Medical
MicroPort
Biosensors
B.Braun
Atrium Medical
Biotronik
Asahi Intecc
Cardinal
Integer
Cook Medical
TE Connectivity
Merit
SP Medical
Percutaneous Transluminal Angioplasty Instrument Segment by Type
Introducer
Angiographic Catheter
Balloon Catheter
Guide Wire
Stent
Others
Percutaneous Transluminal Angioplasty Instrument Segment by Application
Below 40 Years Old
40 ~ 60 Years Old
Above 60 Years Old
Percutaneous Transluminal Angioplasty Instrument Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Percutaneous Transluminal Angioplasty Instrument market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Percutaneous Transluminal Angioplasty Instrument and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Percutaneous Transluminal Angioplasty Instrument.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Percutaneous Transluminal Angioplasty Instrument companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Introducer
- Angiographic Catheter
- Balloon Catheter
- Guide Wire
- Stent
- Others
Applications
- Below 40 Years Old
- 40 ~ 60 Years Old
- Above 60 Years Old
Companies covered
- Abbott
- Boston Scientific
- Medtronic
- Terumo Medical
- Lepu Medical
- MicroPort
- Biosensors
- B.Braun
- Atrium Medical
- Biotronik
- Asahi Intecc
- Cardinal
- Integer
- Cook Medical
- TE Connectivity
- Merit
- SP Medical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Percutaneous Transluminal Angioplasty Instrument by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Introducer
- 2.2.3 Angiographic Catheter
- 2.2.4 Balloon Catheter
- 2.2.5 Guide Wire
- 2.2.6 Stent
- 2.2.7 Others
- 2.3 Percutaneous Transluminal Angioplasty Instrument by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Below 40 Years Old
- 2.3.3 40 ~ 60 Years Old
- 2.3.4 Above 60 Years Old
- 2.4 Assumptions and Limitations
3 Percutaneous Transluminal Angioplasty Instrument Breakdown Data by Type
- 3.1 Global Percutaneous Transluminal Angioplasty Instrument Historic Market Size by Type (2021-2026)
- 3.2 Global Percutaneous Transluminal Angioplasty Instrument Forecasted Market Size by Type (2027-2032)
4 Percutaneous Transluminal Angioplasty Instrument Breakdown Data by Application
- 4.1 Global Percutaneous Transluminal Angioplasty Instrument Historic Market Size by Application (2021-2026)
- 4.2 Global Percutaneous Transluminal Angioplasty Instrument Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Percutaneous Transluminal Angioplasty Instrument Market Perspective (2021-2032)
- 5.2 Global Percutaneous Transluminal Angioplasty Instrument Growth Trends by Region
- 5.2.1 Global Percutaneous Transluminal Angioplasty Instrument Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Percutaneous Transluminal Angioplasty Instrument Historic Market Size by Region (2021-2026)
- 5.2.3 Percutaneous Transluminal Angioplasty Instrument Forecasted Market Size by Region (2027-2032)
- 5.3 Percutaneous Transluminal Angioplasty Instrument Market Dynamics
- 5.3.1 Percutaneous Transluminal Angioplasty Instrument Industry Trends
- 5.3.2 Percutaneous Transluminal Angioplasty Instrument Market Drivers
- 5.3.3 Percutaneous Transluminal Angioplasty Instrument Market Challenges
- 5.3.4 Percutaneous Transluminal Angioplasty Instrument Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Percutaneous Transluminal Angioplasty Instrument Players by Revenue
- 6.1.1 Global Top Percutaneous Transluminal Angioplasty Instrument Players by Revenue (2021-2026)
- 6.1.2 Global Percutaneous Transluminal Angioplasty Instrument Revenue Market Share by Players (2021-2026)
- 6.2 Global Percutaneous Transluminal Angioplasty Instrument Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Percutaneous Transluminal Angioplasty Instrument Head Office and Area Served
- 6.4 Global Percutaneous Transluminal Angioplasty Instrument Players, Product Type & Application
- 6.5 Global Percutaneous Transluminal Angioplasty Instrument Manufacturers Established Date
- 6.6 Global Percutaneous Transluminal Angioplasty Instrument Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032)
- 7.2 North America Percutaneous Transluminal Angioplasty Instrument Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021-2026)
- 7.4 North America Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032)
- 8.2 Europe Percutaneous Transluminal Angioplasty Instrument Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021-2026)
- 8.4 Europe Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032)
- 9.2 Asia-Pacific Percutaneous Transluminal Angioplasty Instrument Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032)
- 10.2 South America Percutaneous Transluminal Angioplasty Instrument Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021-2026)
- 10.4 South America Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032)
- 11.2 Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Abbott
- 12.1.1 Abbott Company Information
- 12.1.2 Abbott Business Overview
- 12.1.3 Abbott Revenue in Percutaneous Transluminal Angioplasty Instrument Business (2021-2026)
- 12.1.4 Abbott Percutaneous Transluminal Angioplasty Instrument Product Portfolio
- 12.1.5 Abbott Recent Developments
- 12.2 Boston Scientific
- 12.2.1 Boston Scientific Company Information
- 12.2.2 Boston Scientific Business Overview
- 12.2.3 Boston Scientific Revenue in Percutaneous Transluminal Angioplasty Instrument Business (2021-2026)
- 12.2.4 Boston Scientific Percutaneous Transluminal Angioplasty Instrument Product Portfolio
- 12.2.5 Boston Scientific Recent Developments
- 12.3 Medtronic
- 12.3.1 Medtronic Company Information
- 12.3.2 Medtronic Business Overview
- 12.3.3 Medtronic Revenue in Percutaneous Transluminal Angioplasty Instrument Business (2021-2026)
- 12.3.4 Medtronic Percutaneous Transluminal Angioplasty Instrument Product Portfolio
- 12.3.5 Medtronic Recent Developments
- 12.4 Terumo Medical
- 12.4.1 Terumo Medical Company Information
- 12.4.2 Terumo Medical Business Overview
- 12.4.3 Terumo Medical Revenue in Percutaneous Transluminal Angioplasty Instrument Business (2021-2026)
- 12.4.4 Terumo Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio
- 12.4.5 Terumo Medical Recent Developments
- 12.5 Lepu Medical
- 12.5.1 Lepu Medical Company Information
- 12.5.2 Lepu Medical Business Overview
- 12.5.3 Lepu Medical Revenue in Percutaneous Transluminal Angioplasty Instrument Business (2021-2026)
- 12.5.4 Lepu Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio
- 12.5.5 Lepu Medical Recent Developments
- 12.6 MicroPort
- 12.6.1 MicroPort Company Information
- 12.6.2 MicroPort Business Overview
- 12.6.3 MicroPort Revenue in Percutaneous Transluminal Angioplasty Instrument Business (2021-2026)
- 12.6.4 MicroPort Percutaneous Transluminal Angioplasty Instrument Product Portfolio
- 12.6.5 MicroPort Recent Developments
- 12.7 Biosensors
- 12.7.1 Biosensors Company Information
- 12.7.2 Biosensors Business Overview
- 12.7.3 Biosensors Revenue in Percutaneous Transluminal Angioplasty Instrument Business (2021-2026)
- 12.7.4 Biosensors Percutaneous Transluminal Angioplasty Instrument Product Portfolio
- 12.7.5 Biosensors Recent Developments
- 12.8 B.Braun
- 12.8.1 B.Braun Company Information
- 12.8.2 B.Braun Business Overview
- 12.8.3 B.Braun Revenue in Percutaneous Transluminal Angioplasty Instrument Business (2021-2026)
- 12.8.4 B.Braun Percutaneous Transluminal Angioplasty Instrument Product Portfolio
- 12.8.5 B.Braun Recent Developments
- 12.9 Atrium Medical
- 12.9.1 Atrium Medical Company Information
- 12.9.2 Atrium Medical Business Overview
- 12.9.3 Atrium Medical Revenue in Percutaneous Transluminal Angioplasty Instrument Business (2021-2026)
- 12.9.4 Atrium Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio
- 12.9.5 Atrium Medical Recent Developments
- 12.10 Biotronik
- 12.10.1 Biotronik Company Information
- 12.10.2 Biotronik Business Overview
- 12.10.3 Biotronik Revenue in Percutaneous Transluminal Angioplasty Instrument Business (2021-2026)
- 12.10.4 Biotronik Percutaneous Transluminal Angioplasty Instrument Product Portfolio
- 12.10.5 Biotronik Recent Developments
- 12.11 Asahi Intecc
- 12.11.1 Asahi Intecc Company Information
- 12.11.2 Asahi Intecc Business Overview
- 12.11.3 Asahi Intecc Revenue in Percutaneous Transluminal Angioplasty Instrument Business (2021-2026)
- 12.11.4 Asahi Intecc Percutaneous Transluminal Angioplasty Instrument Product Portfolio
- 12.11.5 Asahi Intecc Recent Developments
- 12.12 Cardinal
- 12.12.1 Cardinal Company Information
- 12.12.2 Cardinal Business Overview
- 12.12.3 Cardinal Revenue in Percutaneous Transluminal Angioplasty Instrument Business (2021-2026)
- 12.12.4 Cardinal Percutaneous Transluminal Angioplasty Instrument Product Portfolio
- 12.12.5 Cardinal Recent Developments
- 12.13 Integer
- 12.13.1 Integer Company Information
- 12.13.2 Integer Business Overview
- 12.13.3 Integer Revenue in Percutaneous Transluminal Angioplasty Instrument Business (2021-2026)
- 12.13.4 Integer Percutaneous Transluminal Angioplasty Instrument Product Portfolio
- 12.13.5 Integer Recent Developments
- 12.14 Cook Medical
- 12.14.1 Cook Medical Company Information
- 12.14.2 Cook Medical Business Overview
- 12.14.3 Cook Medical Revenue in Percutaneous Transluminal Angioplasty Instrument Business (2021-2026)
- 12.14.4 Cook Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio
- 12.14.5 Cook Medical Recent Developments
- 12.15 TE Connectivity
- 12.15.1 TE Connectivity Company Information
- 12.15.2 TE Connectivity Business Overview
- 12.15.3 TE Connectivity Revenue in Percutaneous Transluminal Angioplasty Instrument Business (2021-2026)
- 12.15.4 TE Connectivity Percutaneous Transluminal Angioplasty Instrument Product Portfolio
- 12.15.5 TE Connectivity Recent Developments
- 12.16 Merit
- 12.16.1 Merit Company Information
- 12.16.2 Merit Business Overview
- 12.16.3 Merit Revenue in Percutaneous Transluminal Angioplasty Instrument Business (2021-2026)
- 12.16.4 Merit Percutaneous Transluminal Angioplasty Instrument Product Portfolio
- 12.16.5 Merit Recent Developments
- 12.17 SP Medical
- 12.17.1 SP Medical Company Information
- 12.17.2 SP Medical Business Overview
- 12.17.3 SP Medical Revenue in Percutaneous Transluminal Angioplasty Instrument Business (2021-2026)
- 12.17.4 SP Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio
- 12.17.5 SP Medical Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst